Medical

Trump FDA: Administration To Review Medical Claims About Marijuana, Cannabis, CBD

Bookmark this Post (0)
ClosePlease login

No account yet? Register

A top Trump administration health official says the federal government may soon begin to proactively examine health claims that marijuana providers are making about their products.

“I see people who are developing products based on marijuana making all kinds of clinical claims in the market. I see people who are developing products making claims that marijuana has anti-tumor effects in the setting of cancer,” Food and Drug Administration Commissioner Scott Gottlieb said in an appearance before Congress on Tuesday.

“And I think reasonable people can ask reasonable questions about whether marijuana is a chemotherapeutic agent,” he said. “It’s a much broader question about where our responsibility is to step into this and start to ask questions about the claims that are being made… We’ll have some answers to this question very soon, because I think we do bear responsibility to start to address these questions.”

https://www.marijuanamoment.net/fda-review-medical-claims-marijuana/

Leave a Reply

Your email address will not be published. Required fields are marked *